Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.7609
-0.0211 (-2.70%)
Mar 3, 2026, 4:00 PM EST - Market closed
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $5.57 million as of March 4, 2026. Its market cap has decreased by -86.03% in one year.
Market Cap
5.57M
Enterprise Value
-1.50M
1-Year Change
-86.03%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $5.57M, a decrease of -97.97%. That is a compound annual growth rate of -59.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 5.72M | -33.16% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
| Nov 1, 2021 | 273.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 6.13M |
| Psyence Biomedical | 6.08M |
| Purple Biotech | 6.02M |
| Aprea Therapeutics | 5.94M |
| Revelation Biosciences | 5.84M |
| Processa Pharmaceuticals | 5.76M |
| Xenetic Biosciences | 5.34M |
| Quince Therapeutics | 5.30M |